What’s Next in Next-Generation Sequencing?

22
Dr. George Church Professor, Department of Genetics Harvard Medical School Dr. George Weinstock Professor of Genetics and Molecular Biology Washington University Dr. Joel Dudley Assistant Professor of Genetics and Genomic Sciences and Director of Biomedical Informatics Mount Sinai School of Medicine Webinar Sponsors What’s Next in Next-Generation Sequencing?

description

What’s Next in Next-Generation Sequencing?. Webinar Sponsors. 1965 1D-RNA sequence Holley, Everett , Madison, Zamir. 2013? Complete 1D genome? 3D-genome? 3D-transcriptome?. 60 yr + 3D. 1953 3D-generic DNA Franklin, Gosling, Watson, Crick, Wilkins, Stokes , Wilson. - PowerPoint PPT Presentation

Transcript of What’s Next in Next-Generation Sequencing?

Page 1: What’s Next in Next-Generation Sequencing?

Dr. George Church Professor, Department of Genetics Harvard Medical School

Dr. George Weinstock Professor of Genetics and Molecular Biology

Washington University

Dr. Joel DudleyAssistant Professor of Genetics and Genomic Sciences and Director of Biomedical Informatics

Mount Sinai School of Medicine

Webinar Sponsors

What’s Next in Next-Generation Sequencing?

Page 2: What’s Next in Next-Generation Sequencing?

60 yr + 3D

19533D-generic DNAFranklin, Gosling, Watson,Crick,Wilkins, Stokes, Wilson

19651D-RNA sequenceHolley, Everett, Madison, Zamir

19773D-RNARich, et al.Klug, et al.Kim, et al.

2013?Complete 1D genome?3D-genome?3D-transcriptome?

Page 3: What’s Next in Next-Generation Sequencing?

1965 1970 1975 1980 1985 1990 1995 2000 2005 2010 2015 2020 2025 2030 2035 20401E+3

1E+4

1E+5

1E+6

1E+7

1E+8

1E+9

1E+10

1E+11

1E+12

1E+13

3

From $3 billion to an affordable genome

When? DNA sequencing& Moore's law

1.5x/yr for electronics

Optimistic’ exponential extrapolation

6 decades

Page 4: What’s Next in Next-Generation Sequencing?

1965 1970 1975 1980 1985 1990 1995 2000 2005 2010 2015 2020 2025 2030 2035 20401E+3

1E+4

1E+5

1E+6

1E+7

1E+8

1E+9

1E+10

1E+11

1E+12

1E+13

4

From $3 billion to an affordable genome

When?

6 years

DNA sequencing& Moore's law

1.5x/yr for electronics

Early arrival

Page 5: What’s Next in Next-Generation Sequencing?

Sequencing via Imaging. Clinical AccuracyHaplotype phase: 2 mutations in cis vs trans

1.43 Mbp LFR CGI/Harvard: Peters, et al. Nature July 2012

10 cells 384 aliquots, ~200 kb size 1 error per 10 million bp (Q70) ! Accurate genome = only 4 Mbytes.

Page 6: What’s Next in Next-Generation Sequencing?

66

1988-1995: Church, Deamer, Branton, Baldarelli, Kasianowicz.

2009 Clarke, Bayley, et al 2010 Derrington, Gundlach, et al 2012 Cherf, Akeson, et al

Nanopore : Polymer vs Monomer vs NanoTag

GG AAA TTT CCC

2012: Oxford & Genia

5 GCAACAGAGCCAGC CCC ′ GCAACAGAGCCAGC AAA GCAACAGAGCCAGC CCC GCAACAGAGCCAGC TTT GCAACAGAGCCAGC GG A A15 3 .′

Page 7: What’s Next in Next-Generation Sequencing?

Nanopore: Polymer vs Monomer vs NanoTag

PEG-Labeled PP: Ju, Kasianowicz, et al. Scientific Reports 2012

“accuracy better than 1 in 5x108 events”A

C G T

Page 8: What’s Next in Next-Generation Sequencing?

8

Fluorescent in situ Sequencing (FISSEQ)60 cycles x 4 colors (3D omes)

Lee, Yang, Terry, Nilsson, Church et al.

Single base differences

Page 9: What’s Next in Next-Generation Sequencing?

Danaher Polonator 2013: Automation & Image Processing

Page 10: What’s Next in Next-Generation Sequencing?

DNA ISH probe

USER cleavage

Probe extension with aminoallyl dUTP

Probe immobilization using BS(PEG)9

••••••••••••••••••••••••••aUaU

RNA

aU aU

RCA primer

aUaU

Phi29

RCA

ISH probe trimming to prevent self-

circularization

RCA with aminoallyl dUTP

Amplicon immobilization using

BS(PEG)9

Fluorescent probe hybridization or

sequencing

aU aU

ssDNA intramolecular circularization

RCA primer hybridization 0 10 20 30 40 50 60

02468

101214

Signal/BackgroundAbs Intensity

Re-probing cycles

RFU

0 1 2 30

100

200

300

400

500

Displacement (um)

Freq

uenc

y

AGCT

6 base sequencing(1 z-slice shown)

Sequencing-by-ligation(1 z-slice shown)

5’ phos

U Nu

CyNu

Cypmpm

pm

nm

Lee, Terry, Daugharty, Turczyk, Scheiman, Yang, Li, Nick Conway; Collaborators --- Kun Zhang, Angela de Pace lab, Feng Zhang, Nilsson

Page 11: What’s Next in Next-Generation Sequencing?

All RNAs GAPDH

Human fibroblast

Page 12: What’s Next in Next-Generation Sequencing?

How can we improve genome interpretation?

How we can make human omics data and cells shareable world-wide?

Page 13: What’s Next in Next-Generation Sequencing?

13

Genomes + Environments = Traits

TRAITS(Phenome)

PERSONAL GENOME3M alleles

Nutrition

Chemicals

Immunome Stem-cellsEpigenome (RNA,mC)

Cancer

PersonalGenomes.org(US, Canada, UK, EU goals: 100,000 volunteers each)

Microbiome

Therapies

Immunome

evidence.personalgenomes.org

Page 14: What’s Next in Next-Generation Sequencing?

14

GenomesEnvironmentsTraits (GET)• World’s only open access data sets• Consented for re-IDentification • 100% on Exam – Educate first• Stem Cell Biobank

0431

1070

1660

1677

1687

1833

1846

1731

1730

1781

Page 15: What’s Next in Next-Generation Sequencing?

15

NIST + FDA + PGP Genome Standards

genomeinabottle.org

“enthusiastic about using samples from the Harvard University's Personal Genome Project, which are broadly consented”, Salit said.

Re-identification & commercial use

http://www.genomeweb.com/sequencing/nist-consortium-embarks-developing-meter-stick-genome-clinical-sequencing

Page 16: What’s Next in Next-Generation Sequencing?

N=1, Genome actionability

Volker: Intestinal surgery XIAPCord blood

Beery twins: Cerebral palsy SPRDiet 5HTP

Wartman: Leukemia FLT3Sunitinib

Gilbert: Healthy BRCA Mas/Ovarectomy

Snyder#82: Healthy GCKR, KCNJ11Diet, exercise

Smarr#74: Crohn’s IL23R Diet, probiotics

Bradfield: Healthy CDH1 GastrectomyPGEd.org 10/18

Page 17: What’s Next in Next-Generation Sequencing?

SupercentenarianStudy.comrare protective alleles

Mortensen 115.7

Breuning 114.6

Calment 122.4

Mirabella 110.6

Page 18: What’s Next in Next-Generation Sequencing?

1818

Correlation → Cause → Cure/Prevention Rare Protective alleles

•MSTN -/- Lean muscles <0.001%•LRP5 -/+ Extra-strong bones 0.001-8%•PCSK9 -/+ Lower coronary disease 3, 0.06% •CCR5 -/- HIV-resistant ~0, 1%•FUT2 -/- Stomach flu resistant 20%•APP -/+ Alzheimer’s 0.4%

blog.personalgenomes.org

Page 19: What’s Next in Next-Generation Sequencing?

1919

N=1, Cause Cure

"Long-Term Control of HIV by CCR5 Δ32/Δ32 Stem-Cell Transplantation" 2009 New England J Medicine

2012: Sangamo Phase 2 clinical trial

2007 Leukemia & AIDS:Timothy Ray Brown

Page 20: What’s Next in Next-Generation Sequencing?

Cas9 CRISPR

RNA-guided human genome engineering. Science in pressMali, Yang, Esvelt, Aach, Guell, DiCarlo, Norville, Church

Page 21: What’s Next in Next-Generation Sequencing?

2121

Brain Activity Map

(BAM+PGP)

GenesEnvironments

Traits

PersonalGenomes.org

Biswal etal PNAS 2010

Page 22: What’s Next in Next-Generation Sequencing?

Dr. George Church Professor, Department of Genetics Harvard Medical School

Dr. George Weinstock Professor of Genetics and Molecular Biology

Washington University

Dr. Joel DudleyAssistant Professor of Genetics and Genomic Sciences and Director of Biomedical Informatics

Mount Sinai School of Medicine

Webinar Sponsors

What’s Next in Next-Generation Sequencing?